Bio-link Australia Pty. Ltd.

Client News

2/14/2019 – Actinogen Medical dose first patient in the XanaHES clinical trial of Xanamem in healthy volunteers…more.

25/05/2018 – Actinogen Medical announce a positive DSMB interim analysis of ph II Alzheimer’s trial and a major $15M placement…more

01/05/2018 – Congratulations to our client, CMRI, for receiving an additional $41 million for the ProCan project…see post.